Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zalviso for post-operative pain after knee or hip replacement
NCT01660763Phase 3Completed
- Sponsor
- Talphera
- Start
- Aug 2012
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of sufentanil in postoperative pain, sponsored by Talphera. Started Aug 2012; status: completed.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01660763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01660763.